| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/13/2003 | US20030032023 Nucleotide sequences coding polypeptide for use in the treatment of cancer and nervous system disorders |
| 02/13/2003 | US20030032021 44589, a novel human ABC transporter family member and uses thereof |
| 02/13/2003 | US20030032005 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents |
| 02/13/2003 | US20030031717 Durable multi-component antibiotic formulation for topical use |
| 02/13/2003 | US20030031716 Biocompatible polymer and particles of metal cation-stabilized interferon dispersed within the polymer |
| 02/13/2003 | US20030031714 Impermeable reservoir with water-swellable agent chamber and drug chamber, fluid is imbibed through a semipermeable plug into the water-swellable agent chamber and the drug is released through back diffusion; treating prostate cancer |
| 02/13/2003 | US20030031709 For sublingual administration of peptides, a mostly anhydrous medium, a non-volatile water soluble solvent, and a topical vasodilator; liquids and tablets |
| 02/13/2003 | US20030031701 Forming a polymer solution/drug mixture of a polymer dissolved in an organic solvent and a suspended labile, removing the solvent and compressing |
| 02/13/2003 | US20030031697 Crosslinkable macromers |
| 02/13/2003 | US20030031686 Exposing a source animal to an antigenic agent to elicit a T-cell mediated immune response, collecting an egg from the source that transfers cellular immunity to another animal in vivo |
| 02/13/2003 | US20030031683 Selecting for a strain of bacteria having an RpoS+ phenotype, inactivating mutations which render the strain attenutated, and a recombinant gene encoding the product |
| 02/13/2003 | US20030031680 Genes and proteins can be used in making transgenic animals and in assays designed to determine the likelihood of an individual developing cardiomyopathy |
| 02/13/2003 | US20030031679 Immunomodulatory peptides derived from heat shock proteins and uses thereof |
| 02/13/2003 | US20030031678 Compositions and methods relating to prostate specific genes and proteins |
| 02/13/2003 | US20030031675 For the immunomodulation of a human or animal; decreasing T-cell proliferation |
| 02/13/2003 | US20030031670 Diagnosis and treatment of malignant neoplasms |
| 02/13/2003 | US20030031669 Non-antigenic toxin-conjugate and fusion protein of internalizing receptor system |
| 02/13/2003 | US20030031668 Treatment of immune complex disease with anti-CD40L antibodies |
| 02/13/2003 | US20030031666 Antibodies that bind IL-13 mutants |
| 02/13/2003 | US20030031665 Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26 |
| 02/13/2003 | US20030031664 For therapy of pulmonary embolism, myocardial infarction, thrombosis or stroke |
| 02/13/2003 | US20030031662 Delivering pituitary tumor transforming gene carboxy-terminal peptide (PTTG-C) to mammalian cell such that the PTTG-C peptide is expressed in the cell, whereby neoplastic cellular proliferation and/or transformation of the cell is inhibited |
| 02/13/2003 | US20030031661 Methods of recovering chaperone proteins and complexes thereof |
| 02/13/2003 | US20030031660 Administering to the subject a therapeutically effective amount of heparanase for inducing bone formation |
| 02/13/2003 | US20030031657 Stem cells and their use in transplantation |
| 02/13/2003 | US20030031655 Methods of light activated release of ligands from endosomes |
| 02/13/2003 | US20030031650 Drug inducible system and use thereof |
| 02/13/2003 | US20030031649 Gene therapy to promote angiogenesis |
| 02/13/2003 | US20030031647 IFN-alpha and amantadine for treating hepatitis C |
| 02/13/2003 | US20030031646 Mammalian chemokines; related reagents |
| 02/13/2003 | US20030031645 Administering to an animal a biologically effective amount of a pharmaceutically acceptable CXC chemokine formulation that comprises an XXX-CXC chemokine other than PF4, the XXX-CXC chemokine lacking the amino acid sequence ELR (Glu Leu Arg) |
| 02/13/2003 | CA2838062A1 Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity |
| 02/13/2003 | CA2753329A1 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 02/13/2003 | CA2456821A1 Human zona pellucida proteins and methods of their use in diagnosing male infertility |
| 02/13/2003 | CA2456196A1 Compositions and methods for modulation of immune responses |
| 02/13/2003 | CA2456177A1 Erythropoietin and anti-tumor necrosis factor alpha combination therapy |
| 02/13/2003 | CA2456092A1 Osteogenic growth oligopeptides as stimulants of hematopoiesis |
| 02/13/2003 | CA2456003A1 Regulator of calcineurin |
| 02/13/2003 | CA2455963A1 Glp-1 exendin-4 peptide analogs and uses thereof |
| 02/13/2003 | CA2455918A1 Hagfish cathelin-associated antimicrobial peptides and genes |
| 02/13/2003 | CA2455711A1 As-needed administration of orally active androgenic agents to enhance female sexual desire and responsiveness |
| 02/13/2003 | CA2455647A1 Enhancing organ maturity in neonates and predicting their duration of intensive care |
| 02/13/2003 | CA2455365A1 Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity |
| 02/13/2003 | CA2455329A1 Vaccine comprising gp120 and nef and/or tat for the immunisation against hiv |
| 02/13/2003 | CA2455228A1 Antisense modulation of apolipoprotein b expression |
| 02/13/2003 | CA2455194A1 Vascular endothelial growth factor isoform having anti-angiogenic activity |
| 02/13/2003 | CA2455154A1 Receptor, the use thereof, and mouse antibodies |
| 02/13/2003 | CA2455147A1 Pregnancy-related enzyme activity |
| 02/13/2003 | CA2455038A1 Antigens of and antibodies to translocated molecules of microorganisms and uses thereof |
| 02/13/2003 | CA2454937A1 Modulators of notch signalling for use in immunotherapy |
| 02/13/2003 | CA2454753A1 Peptides having antiangiogenic activity |
| 02/13/2003 | CA2454454A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 02/13/2003 | CA2454421A1 Use of long pentraxin ptx3 for treating female infertility |
| 02/13/2003 | CA2454066A1 Pulmonary formulation |
| 02/13/2003 | CA2453939A1 Identification of specific tumor antigens by means of the selection of cdna libraries with sera |
| 02/13/2003 | CA2453840A1 Isp-1 and ctb-1 genes and uses thereof |
| 02/13/2003 | CA2453372A1 Methylation resistant vectors |
| 02/13/2003 | CA2453178A1 Commercial use of arabidopsis for production of human and animal therapeutic and diagnostic proteins |
| 02/13/2003 | CA2452524A1 Use of lhrh-antagonists for the improvement of t-cell mediated immunity |
| 02/13/2003 | CA2451942A1 Crystallized structure of type iv collagen nc1 domain hexamer |
| 02/13/2003 | CA2450770A1 Combination of selective cox-2 inhibitor and lung surfactant for respiratory syndrome |
| 02/12/2003 | EP1283268A2 Recombinant vascular endothelial cell growth factor D (VEGF-D) |
| 02/12/2003 | EP1283264A2 Interleukin-3 (IL-3) mutant polypeptides |
| 02/12/2003 | EP1283263A1 Modified cDNA for high expression levels of factor VIII and its derivatives |
| 02/12/2003 | EP1283262A1 Neurotrophic factor expression-inducing agent |
| 02/12/2003 | EP1283260A1 Novel insulin/igf/relaxin family polypeptides and dnas thereof |
| 02/12/2003 | EP1283258A1 Ornithine decarboxylase similar protein and nucleic acid molecules encoding it |
| 02/12/2003 | EP1283255A1 Myocardial cell proliferation-associated genes |
| 02/12/2003 | EP1283217A2 Antibodies against the IL-8 receptor, and their therapeutic uses |
| 02/12/2003 | EP1283216A1 Somatostatin analogues binding to all somatostatin receptor subtypes and their use |
| 02/12/2003 | EP1283059A2 Therapeutic conjugates of toxins and drugs |
| 02/12/2003 | EP1283057A1 Cell proliferation inhibitors |
| 02/12/2003 | EP1283052A1 Pharmaceutical composition containing caspase-8 and /or caspase-9 useful for overcoming glucocorticoid- and cancer therapy-induced apoptosis of tumours |
| 02/12/2003 | EP1283051A1 Stable insulin formulations |
| 02/12/2003 | EP1283050A2 Improved therapeutic compositions comprising bactericidal/permeability-increasing (BPI) protein products |
| 02/12/2003 | EP1283049A1 Depletion of the lysine-pool to suppress malignant proliferation processes |
| 02/12/2003 | EP1283047A1 Method for producing a bioactive substance from blood serum |
| 02/12/2003 | EP1283041A1 Pharmaceutical compositions containing HIV-protease inhibitors |
| 02/12/2003 | EP1283036A1 Dry powder for inhalation |
| 02/12/2003 | EP1283035A2 Therapeutic preparation for inhalation containing parathyroid hormone |
| 02/12/2003 | EP1282727A1 Methods for identifying candidate polynucleotide molecules encoding a protease |
| 02/12/2003 | EP1282725A2 METHODS OF MODULATING FUNCTIONS OF POLYPEPTIDE GalNAc TRANSFERASES AND OF SCREENING SUBSTANCES THEREFORE, PHARMACEUTICAL COMPOSITIONS COMPRISING SUCH AGENTS. |
| 02/12/2003 | EP1282720A2 Glycosyltransferase proteins |
| 02/12/2003 | EP1282711A2 COMPOUNDS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF i EHRLICHIA INFECTION /i |
| 02/12/2003 | EP1282707A2 Regulation of human p2y-like g protein-coupled receptor |
| 02/12/2003 | EP1282705A2 Endothelial differentiation gene 6-like g protein coupled receptor |
| 02/12/2003 | EP1282700A1 Neuronal serine-threonine protein kinase |
| 02/12/2003 | EP1282699A2 Splice-region antisense composition and method |
| 02/12/2003 | EP1282696A1 Ifi206, a novel interferon-induced polypeptide, and nucleic acids encoding the same |
| 02/12/2003 | EP1282693A1 Human coagulation factor vii variants |
| 02/12/2003 | EP1282685A2 Pluripotent cells comprising allogenic nucleus and mitochondria |
| 02/12/2003 | EP1282674A1 Drilling fluids and method of drilling |
| 02/12/2003 | EP1282645A2 G protein-coupled receptors |
| 02/12/2003 | EP1282644A1 Tm4sf receptor polynucleotides, polypeptides, and antibodies |
| 02/12/2003 | EP1282643A2 Anti-inflammatory compounds and uses thereof |
| 02/12/2003 | EP1282642A2 Therapeutic pore-forming peptides |
| 02/12/2003 | EP1282641A1 Human cervical cancer suppressor protein, polynucleotide encoding the protein, cell transformed with the polynucleotide and method for suppressing proliferation of cancer cell using the expression vector |
| 02/12/2003 | EP1282638A1 Peptides and derivatives thereof showing cell attachment, spreading and detachment activity |
| 02/12/2003 | EP1282635A1 Novel nucleic acids and polypeptides |
| 02/12/2003 | EP1282633A1 Mammalian soluble adenylyl cyclase |